Cory Lewis is the founder of INCOG BioPharma. INCOG BioPharma has raised $100M in total funding.
Cory Lewis is the founder, President, and CEO of INCOG BioPharma, a CDMO focused on injectable drug products including vial, syringe, and cartridge filling. He launched the company's capital raising process in February 2020 and closed its Series A financing by September 2020. Lewis brings decades of experience to deliver enhanced CDMO services in the injectable space, with offerings spanning formulation development, analytical testing, stability storage, and device assembly.
Full founder directory · Investor directory · Company funding database · Fundraising library